INO ready for new high
Updated
I have taken a long position in INO here.
INO is in human trials for covid-19 vaccine with safety results expected in late June. Multiple possible catalyst including further funding. NVAX just received $388 million from CEPI and with INO being one of the few in human trials for covid-19 vaccine already, further funding for INO is likely as well.
This is not a recommendation to buy.
This is not financial advice.
INO is in human trials for covid-19 vaccine with safety results expected in late June. Multiple possible catalyst including further funding. NVAX just received $388 million from CEPI and with INO being one of the few in human trials for covid-19 vaccine already, further funding for INO is likely as well.
This is not a recommendation to buy.
This is not financial advice.
Note
Not turning out like I planned so far. Still on high watch. Only a matter of time imo.Trade closed: target reached
Boomshakalaka
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.